Indeed, we have recently shown in human atherosclerosis that TLR-2 and MyD88 play a predominant role in NFκB activation, and in the production of inflammatory mediators, and matrix degrading enzymes in human atherosclerosis [132], suggesting that TLR-2 signaling influences the plaque vulnerability to rupture. The gene discussed is MYD88; the disease is atherosclerosis.